[1]
Ignacio Gainza-Tejedor, Pablo L. Moreno-Flores, Froilán Méndez-Cordovez, Celia Sánchez-Gravie, Çagla Defterali, and Pedro Sánchez-Gómez, “Adherence, acceptability and tolerability of venlafaxine extended release at dose of 300 mg/day in patients with major depressive disorder”, Actas Esp Psiquiatr, vol. 51, no. 5, pp. 193–201, Sep. 2023.